Lincocin

Lincomycin, the active ingredient in Lincocin, is a lincosamide presented as an injectable solution for intravenous use. It treats bacterial infections such as skin and soft‑tissue infections, bone and joint infections, intra‑abdominal infections, and respiratory tract infections in both adult and pediatric patients as prescribed by a healthcare professional.

GNH USA supplies Lincocin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance, and reliable cold‑chain logistics for injectable products.

Lincocin (lincomycin) is employed for bacterial infections affecting various organ systems.

Skin and soft tissue infections: resolves cellulitis and wound infections caused by susceptible Gram‑positive bacteria. Bone and joint infections: treats osteomyelitis and septic arthritis due to lincomycin‑sensitive organisms. Intra‑abdominal infections: eradicates mixed aerobic and anaerobic pathogens in peritonitis and postoperative abdominal infections. Respiratory tract infections: indicated for pneumonia and bronchitis caused by susceptible strains.

Lincomycin may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate feeling of sickness that may be transient. - Diarrhea: loose, watery stools that can lead to dehydration if severe. - Injection site pain or erythema: local discomfort, redness, or swelling at the intravenous insertion point.

Serious or Rare Side Effects: - Clostridioides difficile‑associated colitis: severe, potentially life‑threatening diarrhea caused by overgrowth of C. difficile bacteria. - Severe allergic reaction (anaphylaxis): rapid onset of hives, facial swelling, bronchospasm, and possible circulatory collapse. - Hepatic dysfunction (elevated transaminases): abnormal increase in liver enzymes indicating possible liver injury. Patients should report any persistent or severe symptoms to their healthcare provider promptly.

When using lincomycin, several precautionary measures should be observed to minimize risks. - Renal function assessment: evaluate creatinine clearance before initiating therapy. - Hepatic monitoring: check liver enzymes periodically during treatment. - Hypersensitivity screening: discontinue immediately if rash, itching, or anaphylaxis occurs. - Pregnancy considerations: use only when benefits outweigh potential risks in pregnancy. - Elderly dose adjustment: consider reduced dosing or increased monitoring in older patients. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lincomycin can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Neuromuscular blocking agents: may potentiate muscle weakness during anesthesia. - Erythromycin: antagonistic effect reducing antibacterial activity. - Clindamycin: cross‑resistance may diminish therapeutic effect.

Moderate Interactions (Monitor Closely): - Warfarin: lincomycin may increase INR, requiring closer coagulation monitoring. - Oral contraceptives: possible reduction in hormonal efficacy, advise backup contraception. - Nephrotoxic drugs: concurrent use may increase risk of renal impairment.